Trial of the Safety and Efficacy of Ozarelix in Participants With Benign Prostatic Hyperplasia (BPH)

Clinical trial NCT00743184 · TERMINATED

Trial details

NCT number: NCT00743184
Sponsor: Spectrum Pharmaceuticals, Inc
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia (BPH)Lower Urinary Tract Symptoms (LUTS)

Start date: 2008-12-04
Primary completion: 2010-01-20
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.